Union Minister Dr. Jitendra Singh and IDF President-elect Dr. Niti Pall discussed scaling up indigenous production of biosimilar insulin and diabetes care devices.
The meeting highlighted global insulin supply concerns and India's potential to become a key supplier of affordable insulin and devices.
A stakeholder meeting is planned for July to explore collaborations and scale up manufacturing.